Deudextromethorphan/Bupropion Hydrochloride

氘右美沙芬/安非他酮

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameDeudextromethorphan/Bupropion Hydrochloride
Drug Alias NameSAL-0114
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsP-glycoprotein 1 inhibitorsSigma opioid receptor agonists +[5] 
TargetsSigma opioid receptorGlutamate [NMDA] receptorP-glycoprotein 1 +[5] 
Therapy Area/IndicationsDepressive Disorder, MajorDepressive DisorderDepression +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes DeudextromethorphanBupropion Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDepressive Disorder, MajorDepressive DisorderDepression +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A